E Fund Management (HK)’s Bristol-Myers Squibb BMY Stock Holding History

E Fund Management (HK)’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$29.2K	Buy	507 +80	+19%	+$4.59K	0.01%	240
2026 Q1	$25.9K	Buy	427 +414	+3,185%	+$24.1K	0.01%	194
2025 Q4	$727	Hold	13	–	–	﹤0.01%	297
2025 Q3	$586	Buy	+13	New	+$607	﹤0.01%	264

Other funds holding BMY

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

AIM

Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

FWIA

Fort Washington Investment Advisors Cincinnati, Ohio $19.9B AUM 22.19% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

DLA

Douglas Lane & Associates New York $7.37B AUM 21.9% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

SLAM

Swiss Life Asset Management Zurich $24.1B AUM 38.82% 1-Year Est. Return

Retirement Systems of Alabama Montgomery, Alabama $33.2B AUM 38.15% 1-Year Est. Return

E Fund Management (HK)'s BMY Position: Q2 2026 in Review

E Fund Management (HK) increased its Bristol-Myers Squibb (BMY) stake by 19% in Q2 2026, buying an estimated $4.59K and bringing the position to 507 shares worth $29.2K. The position accounts for 0.01% of the portfolio, ranked #240.

E Fund Management (HK) first reported a position in BMY in Q3 2025 and has held it in 4 quarters since. 1,002 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

E Fund Management (HK) held 507 shares of Bristol-Myers Squibb worth $29.2K as of Q2 2026.
E Fund Management (HK) bought 80 Bristol-Myers Squibb shares in Q2 2026, an estimated $4.59K.
Bristol-Myers Squibb made up 0.01% of E Fund Management (HK)'s portfolio in Q2 2026, its #240 holding.
E Fund Management (HK) first reported a position in Bristol-Myers Squibb in Q3 2025 and has held it in 4 quarters since.
1,002 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on E Fund Management (HK)'s 13F filing for Q2 2026, filed 22 Jul 2026.